Hygea

Hygea Medical Technology Co., Ltd., established in 2010, is headquartered in the "Health Smart Valley" of Haidian District, Beijing. As a national high-tech enterprise integrating research, production, and sales, its business focuses on two minimally invasive fields: "percutaneous intervention" and "vascular intervention." Its debut product, "Cryo-Hyperthermia Knife®," broke the reliance on imported devices for tumor minimally invasive treatments and led the development of the cold-hot composite ablation industry. In 2020, it obtained EU CE certification, marking the beginning of its commercial journey in Europe and achieving reverse technology export. The latest generation "AI Epic Series," with its human-computer interaction and numerical control execution, anticipates the future of medical care and won the 67th iF International Design Award. The company has set up the Beijing Key Laboratory of Cryobiomedical Engineering, a postdoctoral research workstation, and owns more than 150 intellectual property rights domestically and internationally. It has received numerous honors such as being a specialized and innovative "little giant" enterprise, a key technology equipment pilot project in Zhongguancun, a new technology and product from Beijing, and the Youth Civilization Award. We are committed to building an innovative medical device enterprise platform for minimally invasive treatments, helping China's medical devices and minimally invasive technologies achieve a leapfrog advancement.